Horizon Kinetics Asset Management LLC Beam Therapeutics Inc. Transaction History
Horizon Kinetics Asset Management LLC
- $6.03 Billion
- Q3 2024
A detailed history of Horizon Kinetics Asset Management LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 9,194 shares of BEAM stock, worth $238,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,194
Previous 9,597
4.2%
Holding current value
$238,860
Previous $224,000
0.45%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
233Shares Held
75.1MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$213 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$204 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$198 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$170 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$126 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.83B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...